Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1726-1728

  Juárez Rojas, Juan G ^a   Medina Urrutia, Aida X ^a   Jorge Galarza, Esteban ^a   González Salazar, Carmen ^a   Kimura Hayama, Eric ^a   Cardoso Saldaña, Guillermo ^a   Posadas Sánchez, Rosalinda ^a   Martínez Alvarado, Rocio ^a   Posadas Romero, Carlos ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X;

ADULT; AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84878223812     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1276     Document Type: Article

References (15)

1. Eckel RH. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD. Proc Nutr Soc 2007;66:82-95 (Pubitemid 46748247)
2. Ginsberg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009;4:113-119
3. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004;27:2676-2681 (Pubitemid 39441469)
4. Sundström J, Vallhagen E, Risérus U, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006;29:1673-1674 (Pubitemid 44127603)
5. Lattuada G, Ragogna F, Perseghin G. Why does NAFLD predict type 2 diabetes? Curr Diab Rep 2011;11:167-172
6. Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645
7. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
8. Pantongrag-Brown L. Imaging of non-alcoholic fatty liver disease. Thai Journal of Gastroenterology 2010;11:118-122
9. McCollough CH, Ulzheimer S, Halliburton SS, Shanneik K, White RD, Kalender WA. Coronary artery calcium: a multi-institutional, multimanufacturer international standard for quantification at cardiac CT. Radiology 2007;243:527-538 (Pubitemid 46649710)
10. McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008;103:3029-3035
11. Shyangdan D, Clar C, Ghouri N, et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011;15:1-110
12. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320 (Pubitemid 40389097)
13. Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005;25:1045-1050 (Pubitemid 40627853)
14. Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010;254:393-400
15. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-240 (Pubitemid 46400718)